The US medical device sector is entering 2026 with renewed momentum.

After several years of regulatory shifts, supply chain disruption, and cautious capital deployment, device manufacturers are now expanding again — particularly across high-growth, high-complexity areas such as diagnostics, digital health, minimally invasive technologies, and advanced manufacturing.

But while hiring is accelerating, the talent market is tightening.

So what’s driving the surge in recruitment — and where are the real gaps emerging?

1. AI-Enabled Devices Are Moving from Concept to Commercialisation

Artificial intelligence is no longer a “future trend” in medtech. In 2026, AI-driven diagnostics, imaging platforms, wearable monitoring tools, and decision-support software are moving rapidly toward commercial scale.

This shift is increasing demand for:

• Software engineers with regulated product experience
• AI/ML specialists who understand FDA frameworks
• Clinical data scientists
• Regulatory professionals experienced in Software as a Medical Device (SaMD)

The challenge? Candidates who combine deep technical capability with regulatory fluency remain scarce.

2. US-Based Manufacturing Expansion Is Creating New Pressure

Reshoring and regional manufacturing expansion continue across the US, particularly in:

• Sterile manufacturing
• Catheter and minimally invasive device production
• Combination products
• Diagnostic consumables

Facilities are scaling faster than experienced manufacturing talent can be developed internally. As a result, there is heightened competition for:

• Manufacturing engineers
• Process validation specialists
• Quality systems experts
• Supply chain leaders with FDA and ISO 13485 exposure

Companies that delay hiring decisions are increasingly losing top candidates to faster-moving competitors.

3. Regulatory Complexity Is Increasing — Not Easing

Despite innovation speed, regulatory expectations have not relaxed. In fact, global alignment challenges between the US, EU MDR, and UKCA frameworks are creating more strategic regulatory work.

Demand is rising for:

• Regulatory strategy leaders
• Clinical affairs professionals
• Post-market surveillance specialists
• Risk management experts (ISO 14971)

There is a clear shift from purely submission-focused roles toward commercially minded regulatory professionals who can guide product lifecycle strategy.

4. Private Equity and Mid-Sized Firms Are Hiring Aggressively

Mid-market and PE-backed device businesses are particularly active in 2026.

These organisations are often scaling post-acquisition or preparing for commercial expansion. They require leaders who can operate in growth environments — combining operational discipline with strategic thinking.

Hiring demand is strongest for:

• VP and Director-level Quality and Regulatory
• Commercial leadership with US hospital access experience
• Operations leaders who have scaled facilities
• Product development heads with cross-functional exposure

However, many of these leaders are already embedded in stable roles, making proactive search strategies essential.

Where the Talent Gaps Are Most Acute

Across the US medical device market, the most significant shortages are emerging in:

1. AI-regulated product specialists
2. Quality leaders experienced in scaling manufacturing sites
3. Clinical professionals bridging R&D and commercial teams
4. Regulatory strategists with global submission experience
5. Mid-senior manufacturing engineering talent

In many cases, organisations are competing for the same limited talent pools — particularly in innovation hubs such as California, Massachusetts, Minnesota, and Texas.

What This Means for Hiring in 2026

The acceleration of hiring is not temporary. It reflects structural shifts in:

• Digital transformation of devices
• Regulatory complexity
• US manufacturing reinvestment
• Capital returning to medtech innovation

For companies, this means speed, clarity, and strong employer positioning are no longer optional.

For professionals, it signals strong mobility — particularly for those combining technical expertise with regulatory awareness and commercial understanding.

The US medical device market is not just growing in 2026.

It is evolving — and the organisations that secure the right talent now will define the next wave of innovation.